Grantham, Mayo, Van Otterloo & Co (GMO)’s Allient ALNT Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ALNT Stock Details ALNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20,499	Closed	-$701K	–	708
2021 Q1	$701K	Sell	20,499 -2,601	-11%	-$85.9K	﹤0.01%	644
2020 Q4	$787K	Sell	23,100 -4,950	-18%	-$145K	﹤0.01%	605
2020 Q3	$772K	Sell	28,050 -3,150	-10%	-$83.4K	0.01%	563
2020 Q2	$734K	Buy	31,200 +1,950	+7%	+$40.7K	0.01%	581
2020 Q1	$462K	Buy	+29,250	New	+$787K	﹤0.01%	607
2019 Q3	–	Sell	-18,300	Closed	-$462K	–	726
2019 Q2	$462K	Buy	18,300 +8,550	+88%	+$205K	﹤0.01%	611
2019 Q1	$223K	Buy	+9,750	New	+$270K	﹤0.01%	672

Other funds holding ALNT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAM

ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

IMOV

Investment Management of Virginia Richmond, Virginia $526M AUM 3.23% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ALNT Position: Q2 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Allient (ALNT) in Q2 2021, closing a stake of 20,499 shares — an estimated $701K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ALNT in Q1 2019 and held it in 7 quarters. The position peaked at $787K in Q4 2020. 93 funds tracked by Wall St. Rank hold ALNT as of Q2 2021.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Allient position as of Q2 2021 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 20,499 Allient shares in Q2 2021, an estimated $701K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Allient in Q1 2019 and held it in 7 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Allient position peaked at $787K in Q4 2020.
93 funds tracked by Wall St. Rank held Allient as of Q2 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2021, filed 12 Aug 2021.